Please use this identifier to cite or link to this item:
Title: Citrus Flavanone Narirutin, In Vitro and In Silico Mechanistic Antidiabetic Potential
Authors: Qurtam, Ashraf Ahmed $Other$Other
Mechchate, Hamza $Other$Other
Es-safi, Imane $Other$Other
Al-zharani, Mohammed $Other$Other
A. Nasr, Fahd $Other$Other
M. Noman, Omar $Other$Other
Aleissa, Mohammed $Other$Other
Imtara, Hamada$AAUP$Palestinian
M. Aleissa, Abdulmalik $Other$Other
Bouhrim, Mohamed $Other$Other
S. Alqahtani, Ali$Other$Other
Keywords: narirutin
naringenin rutinoside
mechanism of action;
molecular docking
Issue Date: 31-Oct-2021
Publisher: pharmaceutics
Citation: Qurtam, A.A.; Mechchate, H.; Es-safi, I.; Al-zharani, M.; Nasr, F.A.; Noman, O.M.; Aleissa, M.; Imtara, H.; Aleissa, A.M.; Bouhrim, M.; et al. Citrus Flavanone Narirutin, In Vitro and In Silico Mechanistic Antidiabetic Potential. Pharmaceutics 2021, 13, 1818. 10.3390/pharmaceutics13111818
Abstract: Citrus fruits and juices have been studied extensively for their potential involvement in the prevention of various diseases. Flavanones, the characteristic polyphenols of citrus species, are the primarily compounds responsible for these studied health benefits. Using in silico and in vitro methods, we are exploring the possible antidiabetic action of narirutin, a flavanone family member. The goal of the in silico research was to anticipate how narirutin would interact with eight distinct receptors implicated in diabetes control and complications, namely, dipeptidyl-peptidase 4 (DPP4), protein tyrosine phosphatase 1B (PTP1B), free fatty acid receptor 1 (FFAR1), aldose reductase (AldR), glycogen phosphorylase (GP), alpha-amylase (AAM), peroxisome proliferator-activated receptor gamma (PPAR-γ), alpha-glucosidase (AGL), while the in vitro study looked into narirutin’s possible inhibitory impact on alpha-amylase and alpha-glucosidase. The results indicate that the studied citrus flavanone interacted remarkably with most of the receptors and had an excellent inhibitory activity during the in vitro tests suggesting its potent role among the different constituent of the citrus compounds in the management of diabetes and also its complications.
ISSN: 19994923
Appears in Collections:Faculty & Staff Scientific Research publications

Files in This Item:
File Description SizeFormat 
pharmaceutics-13-01818-v2.pdf2.55 MBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Admin Tools